Position in UTHR
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$205,764
-$88,535 QoQ
Shares Held
347
-42.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROTHSCHILD INVESTMENT LLC holds $1,834,012 across 42 Drug Manufacturers - Specialty & Generic names. UTHR ranks #5 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,893 | $512,863 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,216 | $318,840 | |
| 3 | ZTS |
Zoetis Inc.
|
2,182 | $257,934 | |
| 4 | VTRS |
Viatris Inc
|
17,709 | $239,248 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
347 | $205,764 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,452 | $73,854 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
1,040 | $57,522 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
4,266 | $53,026 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $205,764 | 347 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $294,299 | 604 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $77,973 | 186 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $308 | 1 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $352 | 1 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $358 | 1 | Shares | Sole | 2024-10-18 | |
| No filing history on record for this holder in this stock. | ||||||